These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Correct use of methotrexate]. Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852 [TBL] [Abstract][Full Text] [Related]
3. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis. Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165 [TBL] [Abstract][Full Text] [Related]
4. Mucocutaneous ulcerations secondary to methotrexate. Warner J; Brown A; Whitmore SE; Cowan DA Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of methotrexate in psoriasis therapy. Hendel J Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004 [No Abstract] [Full Text] [Related]
6. Ulcerations due to methotrexate toxicity in a psoriasis patient. Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211 [TBL] [Abstract][Full Text] [Related]
7. Cirrhosis associated with methotrexate treatment of psoriasis. Coe RO; Bull FE JAMA; 1968 Nov; 206(7):1515-20. PubMed ID: 5695945 [No Abstract] [Full Text] [Related]
10. The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Belinsky GS; Parke AL; Huang Q; Blanchard K; Jayadev S; Stoll R; Rothe M; Achenie LE; Gupta RR; Wu GY; Rosenberg DW Toxicol Sci; 2007 Jun; 97(2):582-94. PubMed ID: 17400583 [TBL] [Abstract][Full Text] [Related]
11. A risk-benefit assessment of methotrexate in corticosteroid-dependent asthma. Shulimzon TR; Shiner RJ Drug Saf; 1996 Oct; 15(4):283-90. PubMed ID: 8905253 [TBL] [Abstract][Full Text] [Related]
12. A prospective study of the effects of weekly oral methotrexate on liver biopsy. Warin AP; Landells JW; Levene GM; Baker H Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936 [TBL] [Abstract][Full Text] [Related]
13. Viva questions from the IJDVL. Viswanath V; Vasani R Indian J Dermatol Venereol Leprol; 2015; 81(2):226-30. PubMed ID: 25914918 [No Abstract] [Full Text] [Related]
15. [Damage due to treatment of psoriasis with folic acid antagonists]. Randazzo SD; Chiarenza A; Lazzaro C G Ital Dermatol Minerva Dermatol; 1972 Feb; 47(2):77-81. PubMed ID: 4260377 [No Abstract] [Full Text] [Related]
16. A multicentre 12-week open study of a lipid-soluble folate antagonist, piritrexim in severe psoriasis. Perkins W; Williams RE; Vestey JP; Tidman MJ; Layton AM; Cunliffe WJ; Saihan EM; Klaber MR; Manna VK; Baker H Br J Dermatol; 1993 Nov; 129(5):584-9. PubMed ID: 8251356 [TBL] [Abstract][Full Text] [Related]
17. Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases. Ryan TJ; Baker H Br J Dermatol; 1969 Feb; 81(2):134-45. PubMed ID: 4304162 [No Abstract] [Full Text] [Related]
18. Treatment of psoriasis with piritrexim, a lipid-soluble folate antagonist. Guzzo C; Benik K; Lazarus G; Johnson J; Weinstein G Arch Dermatol; 1991 Apr; 127(4):511-4. PubMed ID: 2006875 [TBL] [Abstract][Full Text] [Related]
19. [Reducing toxicity of methotrexate with folic acid]. Harten P Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate in giant-cell arteritis. Morgan SL; Alarcón GS Ann Intern Med; 2001 Dec; 135(11):1006; author reply 1007. PubMed ID: 11730406 [No Abstract] [Full Text] [Related] [Next] [New Search]